---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

Industrifonden

🌎 industrifonden.com

Industrifonden is Sweden’s Venture Capital Fund that invests in early-stage companies, focusing on unique, scalable innovations that improve society through breakthrough technologies and science. The fund specializes in sectors such as life sciences, deep tech, and transformative tech, with an evergreen structure that allows for long-term investments.

---

Updates as of Oct 08, 2024

• Industrifonden participated in a new investment round for Avassa, alongside H&M Group and Fairpoint Capital.
• Industrifonden's portfolio company Treebula has been nominated for the Svenska Designpriset in the Graphic Identity – Redesign Light category.
• Industrifonden led a €3.2M seed funding round for Cellevate to support the global commercialization of their cell culture systems.
• Amadeus Capital Partners' Amelia Armour and Susanne K. Schorsch will attend the Industrifonden Venture Summit on October 10 in Stockholm.
• Susanne K. Schorsch, Partner at Amadeus Capital Partners, will speak at the Industrifonden Venture Summit on October 10.

• Jonathan Ilicki, Principal at Industrifonden, has been chosen as one of the Obama Leaders in Europe.
• Iliam Barkino, Investment Principal at Industrifonden, has returned to the company after a secondment with ZeroPoint Technologies and is now seeking Nordic deep tech startups.
• Industrifonden has announced a new job opening for an 'Investeringsansvarig' in their Life Science team, based in Stockholm with a hybrid remote option.
• Industrifonden has been named a finalist for the 2024 European Lifestars Awards in the VC Firm of the Year category, with three of its portfolio companies also recognized.
• Axel Fridell has joined Industrifonden as a Deep Tech VC Intern in Sweden, previously working on his Master's Thesis at Qliro.
• Asahi Kasei Corporation completed the acquisition of a 98.4% stake in Calliditas Therapeutics AB from Stiftelsen Industrifonden and other shareholders.
• Industrifonden's Investment Director Rebecka Löthman Rydå will speak at the Startup Fair. Pulse 2024 event in Vilnius on October 3rd.
• Industrifonden's portfolio company BOOST Pharma announced positive Phase I/II clinical data showing a 75% reduction in bone fracture rate for Osteogenesis Imperfecta therapy.
• Industrifonden is backing the GoWest tech conference in Gothenburg next year.

---

Did you find it useful?

If you liked this report, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.